168 related articles for article (PubMed ID: 15644473)
1. Obstruction of critical information on over-the-counter medication packages by external tags.
Sansgiry SS; Pawaskar MD
Ann Pharmacother; 2005 Feb; 39(2):249-54. PubMed ID: 15644473
[TBL] [Abstract][Full Text] [Related]
2. Impact of bilingual product information labels on Spanish-speaking adults' ability to comprehend OTC information.
Sansgiry SS; Chanda S; Shringarpure GS
Res Social Adm Pharm; 2007 Dec; 3(4):410-25. PubMed ID: 18082876
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of information on printed over-the-counter drug advertisements.
Sansgiry S; Sharp WT; Sansgiry SS
Health Mark Q; 1999; 17(2):7-18. PubMed ID: 11010213
[TBL] [Abstract][Full Text] [Related]
4. Readability of over-the-counter medication labels.
Sansgiry SS; Cady PS; Patil S
J Am Pharm Assoc (Wash); 1997; NS37(5):522-8. PubMed ID: 9479403
[TBL] [Abstract][Full Text] [Related]
5. An investigative model evaluating how consumers process pictorial information on nonprescription medication labels.
Sansgiry SS; Cady PS
Health Mark Q; 1997; 14(4):71-90. PubMed ID: 10168485
[TBL] [Abstract][Full Text] [Related]
6. Over-the-counter human drugs; labeling requirements. Food and Drug Administration, HHS. Final rule.
Fed Regist; 1999 Mar; 64(51):13254-303. PubMed ID: 10557606
[TBL] [Abstract][Full Text] [Related]
7. Lifestyle or life-saving medicines? A primary healthcare professional and consumer opinion survey on over-the-counter statins.
Vamvakopoulos JE; Kountouri M; Marshall T; Greenfield SM
Ann Pharmacother; 2008 Mar; 42(3):413-20. PubMed ID: 18303145
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of over-the-counter drug-related overdoses at Accident and Emergency departments in Northern Ireland--a retrospective evaluation.
Wazaify M; Kennedy S; Hughes CM; McElnay JC
J Clin Pharm Ther; 2005 Feb; 30(1):39-44. PubMed ID: 15659002
[TBL] [Abstract][Full Text] [Related]
9. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; amendment of final monograph for OTC antitussive drug products. Food and Drug Administration, HHS. Final rule.
Fed Regist; 2000 Aug; 65(148):46864-8. PubMed ID: 11067707
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing consumer purchasing patterns of generic versus brand name over-the-counter drugs.
Kohli E; Buller A
South Med J; 2013 Feb; 106(2):155-60. PubMed ID: 23380752
[TBL] [Abstract][Full Text] [Related]
11. The influence of need for cognition and principal display panel factors on over-the-counter drug facts label comprehension.
Catlin JR; Pechmann C; Brass EP
Health Commun; 2012; 27(3):264-72. PubMed ID: 21899401
[TBL] [Abstract][Full Text] [Related]
12. Organ-specific warnings; internal analgesic, antipyretic, and antirheumatic drug products for over-the-counter human use; final monograph. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2009 Apr; 74(81):19385-409. PubMed ID: 19507324
[TBL] [Abstract][Full Text] [Related]
13. The ability of the geriatric population to read labels on over-the-counter medication containers.
Watanabe RK; Gilbreath K; Sakamoto CC
J Am Optom Assoc; 1994 Jan; 65(1):32-7. PubMed ID: 8132950
[TBL] [Abstract][Full Text] [Related]
14. Enhancing information acquisition for over-the-counter medications by making better use of container surface space.
Wogalter MS; Magurno AB; Dietrich DA; Scott KL
Exp Aging Res; 1999; 25(1):27-48. PubMed ID: 11370108
[TBL] [Abstract][Full Text] [Related]
15. Packaging of pharmaceuticals: still too many dangers but several encouraging initiatives.
Prescrire Int; 2007 Jun; 16(89):126-8. PubMed ID: 17585428
[TBL] [Abstract][Full Text] [Related]
16. Use/misuse of over-the-counter medications and associated adverse drug events among HIV-infected patients.
Ajuoga E; Sansgiry SS; Ngo C; Yeh RF
Res Social Adm Pharm; 2008 Sep; 4(3):292-301. PubMed ID: 18794039
[TBL] [Abstract][Full Text] [Related]
17. Compliance, behavior change, and weight loss with orlistat in an over-the-counter setting.
Schwartz SM; Bansal VP; Hale C; Rossi M; Engle JP
Obesity (Silver Spring); 2008 Mar; 16(3):623-9. PubMed ID: 18239553
[TBL] [Abstract][Full Text] [Related]
18. Labeling of diphenhydramine-containing drug products for over-the-counter human use. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2002 Dec; 67(235):72555-9. PubMed ID: 12474879
[TBL] [Abstract][Full Text] [Related]
19. Examining the conspicuousness and prominence of two required warnings on OTC pain relievers.
Bix L; Bello NM; Auras R; Ranger J; Lapinski MK
Proc Natl Acad Sci U S A; 2009 Apr; 106(16):6550-5. PubMed ID: 19332798
[TBL] [Abstract][Full Text] [Related]
20. Consumer involvement: effects on information processing from over-the-counter medication labels.
Sansgiry SS; Cady PS; Sansgiry S
Health Mark Q; 2001; 19(1):61-78. PubMed ID: 11727293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
